Literature DB >> 26474051

Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.

Alisa B Busch1, Arnold M Epstein, Thomas G McGuire, Sharon-Lise T Normand, Richard G Frank.   

Abstract

BACKGROUND: Examining health care system characteristics possibly associated with 30-day readmission may reveal opportunities to improve healthcare quality as well as reduce costs. AIMS OF THE STUDY: Examine the relationship between 30-day mental health readmission for persons with schizophrenia and county-level community treatment characteristics.
METHODS: Observational study of 18 state Medicaid programs (N=274 counties, representing 103,967 enrollees with schizophrenia 28,083 of whom received more than 1 mental health hospitalization) using Medicaid administrative and United States Area Health Resource File data from 2005. Medicaid is a federal-state program and major health insurance provider for low income and disabled individuals, and the predominant provider of insurance for individuals with schizophrenia. The Area Health Resource File provides county-level estimates of providers. We first fit a regression model examining the relationship between 30-day mental health readmission and enrollee characteristics (e.g., demographics, substance use disorder [SUD], and general medical comorbidity) from which we created a county-level demographic and comorbidity case-mix adjuster. The case-mix adjuster was included in a second regression model examining the relationship between 30-day readmission and county-level factors: (i) quality (antipsychotic/visit continuity, post-hospital follow-up); (ii) mental health hospitalization (length of stay, admission rates); and (iii) treatment capacity (e.g., population-based estimates of outpatient providers/clinics). We calculated predicted probabilities of readmission for significant patient and county-level variables.
RESULTS: Higher county rates of mental health visits within 7-days post-hospitalization were associated with lower readmission probabilities (e.g., county rates of 7-day follow up of 55% versus 85%, readmission predicted probability (PP) [95%CI]=16.1% [15.8%-16.4%] versus 13.3% [12.9%-13.6%]). In contrast, higher county rates of mental health hospitalization were associated with higher readmission probabilities (e.g., country admission rates 10% versus 30%, readmission predicted probability=11.3% [11.0%-11.6%] versus 16.7% [16.4%-17.0%]). Although not our primary focus, enrollee comorbidity was associated with higher predicted probability of 30-day mental health readmission: PP [95%CI] for enrollees with SUD=23.9% [21.5%-26.3%] versus 14.7% [13.9%-15.4%] for those without; PP [95% CI] for those with=three chronic medical conditions=25.1% [22.1%-28.2%] versus none=17.7% [16.3%-19.1]. DISCUSSION: County rates of hospitalization and 7-day follow-up post hospital discharge were associated with readmission, along with patient SUD and general medical comorbidity. This observational design limits causal inference and utilization patterns may have changed since 2005. However, overall funding for U.S. Medicaid programs remained constant since 2005, reducing the likelihood significant changes. Last, our inability to identify community capacity variables associated with readmission may reflect imprecision of some variables as measured in the Area Health Resource File. IMPLICATIONS FOR HEALTH CARE PROVISION AND USE AND FOR HEALTH POLICIES: Healthcare policy and programming to reduce 30-day mental health readmissions should focus on county-level factors that contribute to hospitalization in general and improving transitions to community care, as well as patient comorbidity. IMPLICATIONS FOR FURTHER RESEARCH: Given the likely importance of local care systems, to reduce readmission future research is needed to refine community-level capacity variables that are associated with reduced readmissions; and to evaluate models of care coordination in this population.

Entities:  

Mesh:

Year:  2015        PMID: 26474051      PMCID: PMC4764135     

Source DB:  PubMed          Journal:  J Ment Health Policy Econ        ISSN: 1099-176X


  22 in total

Review 1.  Psychosocial approaches to dual diagnosis.

Authors:  R E Drake; K T Mueser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

3.  Predictors of early psychiatric readmission.

Authors:  R Nicolson; A Feinstein
Journal:  Psychiatr Serv       Date:  1996-02       Impact factor: 3.084

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

Review 5.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

6.  Length of first admission and treatment outcome in patients with unipolar depression.

Authors:  Christoph Lauber; Barbara Lay; Wulf Rössler
Journal:  J Affect Disord       Date:  2006-03-13       Impact factor: 4.839

7.  Use of claims data to examine the impact of length of inpatient psychiatric stay on readmission rate.

Authors:  Roberto Figueroa; Jeffrey Harman; John Engberg
Journal:  Psychiatr Serv       Date:  2004-05       Impact factor: 3.084

8.  Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Authors:  Marcia Valenstein; Laurel A Copeland; Frederic C Blow; John F McCarthy; John E Zeber; Leah Gillon; C Raymond Bingham; Thomas Stavenger
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

9.  Changes over time and disparities in schizophrenia treatment quality.

Authors:  Alisa B Busch; Anthony F Lehman; Howard Goldman; Richard G Frank
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

10.  Symptom severity and number of previous psychiatric admissions as predictors of readmission.

Authors:  C Swett
Journal:  Psychiatr Serv       Date:  1995-05       Impact factor: 3.084

View more
  5 in total

1.  Factors Related to 30-day Readmission following Hospitalization for Any Medical Reason among Patients with Mental Disorders: Facteurs liés à la réhospitalisation à 30 jours suivant une hospitalisation pour une raison médicale chez des patients souffrant de troubles mentaux.

Authors:  Lia Gentil; Guy Grenier; Marie-Josée Fleury
Journal:  Can J Psychiatry       Date:  2020-10-16       Impact factor: 4.356

2.  Care Management Intervention to Decrease Psychiatric and Substance Use Disorder Readmissions in Medicaid-Enrolled Adults.

Authors:  Shari L Hutchison; Jenny V Flanagan; Irina Karpov; Lisa Elliott; Brandi Holsinger; Jamie Edwards; David Loveland
Journal:  J Behav Health Serv Res       Date:  2019-07       Impact factor: 1.505

3.  Measures of Care Coordination at Inpatient Psychiatric Facilities and the Medicare 30-Day All-Cause Readmission Rate.

Authors:  Ivy Benjenk; Morgan Shields; Jie Chen
Journal:  Psychiatr Serv       Date:  2020-08-25       Impact factor: 3.084

4.  Behavioral health home impact on transitional care and readmissions among adults with serious mental illness.

Authors:  Alene Kennedy-Hendricks; Sachini Bandara; Gail L Daumit; Alisa B Busch; Elizabeth M Stone; Elizabeth A Stuart; Karly A Murphy; Emma E McGinty
Journal:  Health Serv Res       Date:  2020-10-29       Impact factor: 3.734

5.  A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.

Authors:  Anna Alonso-Solís; Susana Ochoa; Eva Grasa; Katya Rubinstein; Asaf Caspi; Kinga Farkas; Zsolt Unoka; Judith Usall; Elena Huerta-Ramos; Matti Isohanni; Jussi Seppälä; Elisenda Reixach; Jesús Berdún; Iluminada Corripio; M-Resist Group
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.